Welcome to San Francisco Biotech Networks DAILY for 01/11/2026. Daily news and jobs are listed below. Please forward this email to your colleagues so they can subscribe at biotechnetworks.org/daily

​​​​​​​

Click a link below to view the mailing archive as if it had been sent to you.

2021-11-30 01:30CohBar’s CEO to Participate in Upcoming BIO Webinar and more...
2021-11-27 01:30Akero Therapeutics to Present at the Evercore ISI 4th Annual HealthCONx Virtual Conference and more...
2021-11-26 01:30IASO Biotheraputics' CT120 Granted Orphan Drug Designation by the U.S. FDA
2021-11-25 01:30Kronos Bio Announces Participation in Upcoming Investor Conferences and more...
2021-11-24 01:30AcelRx Pharmaceuticals Announces the Appointment of Jill Broadfoot to its Board of Directors and more...
2021-11-23 01:30After failed Illumina deal, new PacBio CEO builds for the long run and the short read and more...
2021-11-22 01:30Innovent Releases the ORIENT-31 Phase 3 Study First Interim Analysis Results of Sintilimab plus BYVASDA (bevacizumab biosimilar injection) and Chemotherapy in Patients with EGFR-mutated Nonsquamous Non-small Cell Lung Cancer who Progressed ...
2021-11-21 01:30PacBio Grants Equity Incentive Award to New Employee and more...
2021-11-20 01:30Neurona Therapeutics to Present at the Piper Sandler 33rd Annual Healthcare Conference and more...
2021-11-19 01:30Second Genome Presents Preclinical Data at Crohn's & Colitis Foundation's® IBD Innovate Conference for Potential First in Class Mucosal Healing Therapeutic SG-5-00455 and more...
2021-11-18 01:30U.S. makes $1B order for Vir's Covid-fighting drug and more...
2021-11-17 01:30L’Oréal fellow Lilia Xie expresses herself through materials chemistry and more...
2021-11-16 01:30Amyris Closes Upsized Offering Of $690.0 Million Of 1.50% Convertible Senior Notes Due 2026 and more...
2021-11-15 01:30Innovent Announces the Results of the Phase Ib Clinical Trial of IBI302, a First-in-class Anti-VEGF and Anti-Complement Bi-specific Fusion Protein for Neovascular Age-Related Macular Degeneration at 2021 American Academy of Ophthalmology
2021-11-14 01:30Jasper Therapeutics Announces Third Quarter 2021 Financial Results and Provides Business Update and more...
2021-11-13 01:30Humanigen Reports Third Quarter and Nine Months Ending September 30, 2021 Financial Results and Provides Corporate Update and more...
2021-11-12 01:30Personalis to Present New Data at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting and more...
2021-11-11 01:30Tivic Health Systems, Inc. Announces Pricing of Initial Public Offering and more...
2021-11-10 01:30Geron Presents Investor Event Highlights and more...
2021-11-09 01:30Why a onetime biotech IPO hopeful shifted to a 'blank check' deal and more...
2021-11-06 01:30Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) and more...
2021-11-05 01:30East Bay drug maker to appeal FDA rejection of kidney treatment and more...
2021-11-04 01:30Guardant Health and The Royal Marsden NHS Foundation Trust Announce Partnership to Establish First Guardant Health Liquid Biopsy Testing Service Based in the United Kingdom and more...
2021-11-03 01:30FeedKind® Significantly Reduces Vibrio in Shrimp, Improves Survival During an EMS Challenge and more...
2021-11-02 01:3023andMe Announces the Closing of its Acquisition of Lemonaid Health and more...

 

<< Archive Index • Subscribe >>

 

© Biotech Networks. You're receiving this email because you've signed up to receive updates from us.

If you'd prefer not to receive updates, you can unsubscribe.
 
© FeedBlitz® - Win the Inbox ™ | feedblitz.com | info@feedblitz.com | Privacy | Terms of Service
 English | Português | Français | Español | Italiano | Nederlands | Svenska | Deutsch | 日本語